A three-month interval between the first and second doses of the ChAdOx1 nCoV-19 Oxford vaccine results in higher vaccine efficacy than a six-week interval, according to a study published online Feb....
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok